Literature DB >> 1141212

Glycosphingolipids of human KB cells grown in monolayer, suspension, and synchronized cultures.

S Chatterjee, C C Sweeley, L F Velicer.   

Abstract

Studies have been carried out on the glycosphingolipids of human KB cells grown in monolayer and suspension culture, and by synchronization of the latter with a double thymidine (2mM) block. Glycosphingolipids were identified tentatively by thin layer chromatography, gas-liquid chromatography, and combined gas-liquid chromatography and mass spectrometry. The predominant gangliosides in the these cells were AcNeu-Gal-Glc-Cer and AcNeu-Gal-GalNAc-Gal-(AcNeu). Glc-Cer. Theprincipal neutral glycosphingolipids were Glc-Cer, Gal-Glc-Cer, Gal-Gal-Glc-Cer, and GalNAc-Gal-Gal-Glc-Cer. Incubation of KB cells (grown in monolayer and subsequently in suspension culture) for 48 hours with D-[1-14Clgalactose resulted in appreciable incorporation of radioactivity into all of the principal glycosphingolipids of these cells. These experiments confirmed that KB cells are capable of synthesizing their constituent glycosphingolipids. KB cells grown in suspension culture showed A 2- to 3-fold increase inthe concentration of Glc-Cer, Gal-Glc-Cer, GalNAc-Gal-Gal-Glc-Cer, and AcNeu-Gal1NAc-Gal-Gal-Glc-Cer, and AcNeu-Gal-Ga1NAcGal-(AcNeu)-Glc-Cer. Thus, the occurrence of tissue culture-dependent changes in the level of glycosphingolipids is demonstrated. Perhaps messages governing the synthesis of glycosphingolipids are translated earlier in thecell cycle under certain conditions of growth and are affected by cell-cell contact and cell adhesion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1141212

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  The hypothesis on function of glycosphingolipids and ABO blood groups revisited.

Authors:  Jerzy Kościelak
Journal:  Neurochem Res       Date:  2012-03-11       Impact factor: 3.996

2.  Deletion of complex gangliosides of human glioma cells during mitotic cell division.

Authors:  B O Choi; T Yamaki; K Tatewaki; Y Ibayashi; K Hashi
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

3.  Long-chain neutral glycolipids and gangliosides of murine fibroblast lines and their low- and high-tumourigenic hybrids.

Authors:  K Itaya; S I Hakomori; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

4.  Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation.

Authors:  Yuko Oda; Yoshikazu Uchida; Sam Moradian; Debra Crumrine; Peter M Elias; Daniel D Bikle
Journal:  J Invest Dermatol       Date:  2008-12-04       Impact factor: 8.551

5.  Glycosphingolipids of human plasma lipoproteins.

Authors:  S Chatterjee; P O Kwiterovich
Journal:  Lipids       Date:  1976-06       Impact factor: 1.880

6.  Alterations of neutral glycolipids in cells infected with syncytium-producing mutants of herpes simplex virus type 1.

Authors:  M A Ruhlig; S Person
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

7.  Alterations in cell surface glycosphingolipids and other lipid classes of fibroblasts in familial hypercholesterolemia.

Authors:  S Chatterjee; C S Sekerke; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

8.  Gangliosides of cultured cells of a rat mammary carcinoma cell line.

Authors:  T W Keenan; E Schmid; W W Franke
Journal:  Lipids       Date:  1978-06       Impact factor: 1.880

Review 9.  Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.

Authors:  Irina V Kholodenko; Daniel V Kalinovsky; Igor I Doronin; Sergey M Deyev; Roman V Kholodenko
Journal:  J Immunol Res       Date:  2018-07-11       Impact factor: 4.818

10.  Thylakoid membrane biogenesis in Chlamydomonas reinhardtii 137+: cell cycle variations in the synthesis and assembly of polar glycerolipid.

Authors:  D R Janero; R Barrnett
Journal:  J Cell Biol       Date:  1981-10       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.